3-methylglutaconic aciduria (3-MGCA) is a biochemical finding in a diverse group of inherited metabolic disorders. Conditions manifesting 3-MGCA are classified into two major categories, primary and secondary. Primary 3-MGCAs involve two inherited enzymatic deficiencies affecting leucine catabolism, whereas secondary 3-MGCAs comprise a larger heterogeneous group of conditions that have in common compromised mitochondrial energy metabolism. Here, we report 3-MGCA in two siblings presenting with sensorineural hearing loss and neurological abnormalities associated with a novel, homozygous missense variant (c.1999C>G, p.Leu667Val) in the YME1L1 gene which encodes a mitochondrial ATP-dependent metalloprotease. We show that the identified variant results in compromised YME1L1 function, as evidenced by abnormal proteolytic processing of substrate proteins, such as OPA1 and PRELID1. Consistent with the aberrant processing of the mitochondrial fusion protein OPA1, we demonstrate enhanced mitochondrial fission and fragmentation of the mitochondrial network in patient-derived fibroblasts. Furthermore, our results indicate that YME1L1L667V is associated with attenuated activity of rate-limiting Krebs cycle enzymes and reduced mitochondrial respiration, which may explain the build-up of 3-methylglutaconic and 3-methylglutaric acid due to the diversion of acetyl-CoA, not efficiently processed in the Krebs cycle, towards the formation of 3-methylglutaconyl-CoA, the precursor of these metabolites. In summary, our findings classify YME1L1 deficiency as a new type of secondary 3-MGCA, thus expanding the genetic landscape and facilitating the diagnosis of inherited metabolic disorders featuring this biochemical phenotype.

Biochemical Genetics Department The Cyprus Institute of Neurology and Genetics Nicosia Cyprus

Cytogenetics and Genomics Department The Cyprus Institute of Neurology and Genetics Nicosia Cyprus

Department of Paediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University General University Hospital Prague Czech Republic

Department of Paediatrics Inborn Errors of Metabolism Clinic Archbishop Makarios 3 Hospital State Health Services Organisation Nicosia Cyprus

Karaiskakio Foundation Nicosia Cyprus and Archbishop Makarios 3 Hospital State Health Services Organisation Nicosia Cyprus

Neolab SA Medical Laboratory Athens Greece

Paediatric Neurology Clinic Archbishop Makarios 3 Hospital State Health Services Organisation Nicosia Cyprus

Zobrazit více v PubMed

Jones D. E., Klacking E., and Ryan R. O., “Inborn Errors of Metabolism Associated With 3‐Methylglutaconic Aciduria,” Clinica Chimica Acta 522 (2021): 96–104. PubMed PMC

Jones D. E., Romenskaia I., Kosma D. K., and Ryan R. O., “Role of Non‐Enzymatic Chemical Reactions in 3‐Methylglutaconic Aciduria,” FEBS Journal 289, no. 10 (2022): 2948–2958. PubMed PMC

Wortmann S. B., Duran M., Anikster Y., et al., “Inborn Errors of Metabolism With 3‐Methylglutaconic Aciduria as Discriminative Feature: Proper Classification and Nomenclature,” Journal of Inherited Metabolic Disease 36, no. 6 (2013): 923–928. PubMed

Su B. and Ryan R. O., “Metabolic Biology of 3‐Methylglutaconic Acid‐Uria: A New Perspective,” Journal of Inherited Metabolic Disease 37, no. 3 (2014): 359–368. PubMed PMC

Jones D. E., Perez L., and Ryan R. O., “3‐Methylglutaric Acid in Energy Metabolism,” Clinica Chimica Acta 502 (2020): 233–239. PubMed PMC

Wortmann S. B., Kluijtmans L. A., Engelke U. F., Wevers R. A., and Morava E., “The 3‐Methylglutaconic Acidurias: What's New?,” Journal of Inherited Metabolic Disease 35, no. 1 (2012): 13–22. PubMed PMC

Messina M., Vaz F. M., and Rahman S., “Mitochondrial Membrane Synthesis, Remodelling and Cellular Trafficking,” Journal of Inherited Metabolic Disease 48, no. 1 (2025): e12766. PubMed PMC

Wortmann S. B., Kluijtmans L. A., Rodenburg R. J., et al., “3‐Methylglutaconic Aciduria‐‐Lessons from 50 Genes and 977 Patients,” Journal of Inherited Metabolic Disease 36, no. 6 (2013): 913–921. PubMed

Hartmann B., Wai T., Hu H., et al., “Homozygous YME1L1 Mutation Causes Mitochondriopathy With Optic Atrophy and Mitochondrial Network Fragmentation,” eLife (2016): 5. PubMed PMC

Rinaldo P., “Organic Acids,” in Laboratory Guide to the Methods in Biochemical Genetics, ed. Blau N., Duran M., and Gibson K. M. (Springer Berlin Heidelberg, 2008), 137–169.

Chaudhry A., Shi R., and Luciani D. S., “A Pipeline for Multidimensional Confocal Analysis of Mitochondrial Morphology, Function, and Dynamics in Pancreatic Beta‐Cells,” American Journal of Physiology. Endocrinology and Metabolism 318, no. 2 (2020): E87–E101. PubMed PMC

Dougherty R., ed., Extensions of DAMAS and Benefits and Limitations of Deconvolution in Beamforming. 11th AIAA/CEAS Aeroacoustics Conference 2005.

Smith P. K., Krohn R. I., Hermanson G. T., et al., “Measurement of Protein Using Bicinchoninic Acid,” Analytical Biochemistry 150, no. 1 (1985): 76–85. PubMed

Ruijter J. M., Ramakers C., Hoogaars W. M., et al., “Amplification Efficiency: Linking Baseline and Bias in the Analysis of Quantitative PCR Data,” Nucleic Acids Research 37, no. 6 (2009): e45. PubMed PMC

Srere P. A., “Citrate Synthase. [EC 4.1.3.7. Citrate Oxaloacetate‐Lyase (CoA‐Acetylating)],” Methods in Enzymology 13 (1969): 3–11.

Rustin P., Chretien D., Bourgeron T., et al., “Biochemical and Molecular Investigations in Respiratory Chain Deficiencies,” Clinica Chimica Acta 228, no. 1 (1994): 35–51. PubMed

Robinson J., Brent L., Sumegi B., and Srere P., “An Enzymatic Approach to the Study of the Krebs Tricarboxylic Acid Cycle,” Mitochondria: A Practical Approach (1987): 153–170.

Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J., “Protein Measurement With the Folin Phenol Reagent,” Journal of Biological Chemistry 193, no. 1 (1951): 265–275. PubMed

Sievers F., Wilm A., Dineen D., et al., “Fast, Scalable Generation of High‐Quality Protein Multiple Sequence Alignments Using Clustal Omega,” Molecular Systems Biology 7 (2011): 539. PubMed PMC

Wai T., Saita S., Nolte H., et al., “The Membrane Scaffold SLP2 Anchors a Proteolytic Hub in Mitochondria Containing PARL and the i‐AAA Protease YME1L,” EMBO Reports 17, no. 12 (2016): 1844–1856. PubMed PMC

Leonhard K., Herrmann J. M., Stuart R. A., Mannhaupt G., Neupert W., and Langer T., “AAA Proteases With Catalytic Sites on Opposite Membrane Surfaces Comprise a Proteolytic System for the ATP‐Dependent Degradation of Inner Membrane Proteins in Mitochondria,” EMBO Journal 15, no. 16 (1996): 4218–4229. PubMed PMC

Shah Z. H., Hakkaart G. A., Arku B., et al., “The Human Homologue of the Yeast Mitochondrial AAA Metalloprotease Yme1p Complements a Yeast yme1 Disruptant,” FEBS Letters 478, no. 3 (2000): 267–270. PubMed

MacVicar T. and Langer T., “OPA1 Processing in Cell Death and Disease ‐ The Long and Short of It,” Journal of Cell Science 129, no. 12 (2016): 2297–2306. PubMed

Rainey R. N., Glavin J. D., Chen H. W., French S. W., Teitell M. A., and Koehler C. M., “A New Function in Translocation for the Mitochondrial i‐AAA Protease Yme1: Import of Polynucleotide Phosphorylase Into the Intermembrane Space,” Molecular and Cellular Biology 26, no. 22 (2006): 8488–8497. PubMed PMC

Graef M., Seewald G., and Langer T., “Substrate Recognition by AAA+ ATPases: Distinct Substrate Binding Modes in ATP‐Dependent Protease Yme1 of the Mitochondrial Intermembrane Space,” Molecular and Cellular Biology 27, no. 7 (2007): 2476–2485. PubMed PMC

Stiburek L., Cesnekova J., Kostkova O., et al., “YME1L Controls the Accumulation of Respiratory Chain Subunits and Is Required for Apoptotic Resistance, Cristae Morphogenesis, and Cell Proliferation,” Molecular Biology of the Cell 23, no. 6 (2012): 1010–1023. PubMed PMC

Van Dyck L. and Langer T., “ATP‐Dependent Proteases Controlling Mitochondrial Function in the Yeast Saccharomyces cerevisiae,” Cellular and Molecular Life Sciences 56, no. 9‐10 (1999): 825–842. PubMed PMC

Anand R., Wai T., Baker M. J., et al., “The i‐AAA Protease YME1L and OMA1 Cleave OPA1 to Balance Mitochondrial Fusion and Fission,” Journal of Cell Biology 204, no. 6 (2014): 919–929. PubMed PMC

Wai T., Garcia‐Prieto J., Baker M. J., et al., “Imbalanced OPA1 Processing and Mitochondrial Fragmentation Cause Heart Failure in Mice,” Science 350, no. 6265 (2015): aad0116. PubMed

Sprenger H. G., Wani G., Hesseling A., et al., “Loss of the Mitochondrial i‐AAA Protease YME1L Leads to Ocular Dysfunction and Spinal Axonopathy,” EMBO Molecular Medicine 11, no. 1 (2019). PubMed PMC

Del Dotto V., Fogazza M., Carelli V., Rugolo M., and Zanna C., “Eight Human OPA1 Isoforms, Long and Short: What Are They for?,” Biochimica et Biophysica Acta ‐ Bioenergetics 1859, no. 4 (2018): 263–269. PubMed

Potting C., Tatsuta T., Konig T., et al., “TRIAP1/PRELI Complexes Prevent Apoptosis by Mediating Intramitochondrial Transport of Phosphatidic Acid,” Cell Metabolism 18, no. 2 (2013): 287–295. PubMed

Baker M. J., Blau K. U., Anderson A. J., et al., “CLPB Disaggregase Dysfunction Impacts the Functional Integrity of the Proteolytic SPY Complex,” Journal of Cell Biology 223, no. 3 (2025): e202305087. PubMed PMC

Wortmann S. B., Zietkiewicz S., Kousi M., et al., “CLPB Mutations Cause 3‐Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement Disorder,” American Journal of Human Genetics 96, no. 2 (2015): 245–257. PubMed PMC

Smith A. N., Wang X., Thomas D. G., Tatum R. E., Booz G. W., and Cunningham M. W., “The Role of Mitochondrial Dysfunction in Preeclampsia: Causative Factor or Collateral Damage?,” American Journal of Hypertension 34, no. 5 (2021): 442–452. PubMed

Ausman J., Abbade J., Ermini L., et al., “Ceramide‐Induced BOK Promotes Mitochondrial Fission in Preeclampsia,” Cell Death & Disease 9, no. 3 (2018): 298. PubMed PMC

Olahova M., Thompson K., Hardy S. A., et al., “Pathogenic Variants in HTRA2 Cause an Early‐Onset Mitochondrial Syndrome Associated With 3‐Methylglutaconic Aciduria,” Journal of Inherited Metabolic Disease 40, no. 1 (2017): 121–130. PubMed PMC

Liu X., Weaver D., Shirihai O., and Hajnoczky G., “Mitochondrial 'Kiss‐And‐Run': Interplay Between Mitochondrial Motility and Fusion‐Fission Dynamics,” EMBO Journal 28, no. 20 (2009): 3074–3089. PubMed PMC

Lam C., Gallo L. K., Dineen R., et al., “Two Novel Compound Heterozygous Mutations in OPA3 in Two Siblings With OPA3‐Related 3‐Methylglutaconic Aciduria,” Molecular Genetics and Metabolism Reports 1 (2014): 114–123. PubMed PMC

Suissa M., Suda K., and Schatz G., “Isolation of the Nuclear Yeast Genes for Citrate Synthase and Fifteen Other Mitochondrial Proteins by a New Screening Method,” EMBO Journal 3, no. 8 (1984): 1773–1781. PubMed PMC

Weitzman P. D. and Danson M. J., “Citrate Synthase,” Current Topics in Cellular Regulation 10 (1976): 161–204. PubMed

Chinopoulos C., “Which Way Does the Citric Acid Cycle Turn During Hypoxia? The Critical Role of Alpha‐Ketoglutarate Dehydrogenase Complex,” Journal of Neuroscience Research 91, no. 8 (2013): 1030–1043. PubMed

Jones D. E., Jennings E. A., and Ryan R. O., “Diversion of Acetyl CoA to 3‐Methylglutaconic Acid Caused by Discrete Inborn Errors of Metabolism,” Metabolites 12, no. 5 (2022). PubMed PMC

Riggs E. R., Andersen E. F., Cherry A. M., et al., “Technical Standards for the Interpretation and Reporting of Constitutional Copy‐Number Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen),” Genetics in Medicine 22, no. 2 (2020): 245–257. PubMed PMC